enGene
Christine Zouki is a seasoned professional in the field of biomedical sciences with extensive experience in research and development. Currently serving as a Senior Research Associate at Engene Inc since June 2018, Christine has previously held positions at Paraza Pharma Inc. as a Senior Associate Scientist specializing in DMPK from October 2013 to May 2015, and at Boehringer Ingelheim from September 2000 to March 2013 as a Research Associate focusing on ADME-PK and in-vitro studies. Christine began a career in research as a Research Assistant at the Royal-Victoria Hospital's Cardiovascular Research Unit from 1997 to 1998. Christine holds a Master of Science (MSc) degree in Biomedical Sciences from Université de Montréal, completed between 1998 and 2000.
enGene
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications